Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl-Johan Malmberg

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Cancer Immunology, Immunotherapy : CII|September 1, 2004
Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape?Karl-Johan Malmberg
Cancer Cell|September 19, 2025
Rewiring natural killer cells for next-generation cancer therapiesAline Pfefferle, Karl-Johan Malmberg
Cell Calcium|October 7, 2020
Preventing a shock to the system. Two-pore channel 1 negatively regulates anaphylaxisSandip Patel, Karl-Johan Malmberg
Seminars in Cancer Biology|September 6, 2005
Escape from immune- and nonimmune-mediated tumor surveillanceKarl-Johan Malmberg, Hans-Gustaf Ljunggren
Nature Immunology|December 18, 2008
Spotlight on IL-22-producing NK cell receptor-expressing mucosal lymphocytesKarl-Johan Malmberg, Hans-Gustaf Ljunggren
Nature Reviews. Immunology|April 18, 2007
Prospects for the use of NK cells in immunotherapy of human cancerHans-Gustaf Ljunggren, Karl-Johan Malmberg
Blood Cancer Discovery|April 17, 2026
CAR-NK Cells in B-cell Lymphoma: A New Frontier toward Accessible and Scalable Cellular TherapyRémy Duléry, Karl-Johan Malmberg, Rizwan Romee
Current Protocols|November 28, 2022
Small Interfering RNA Delivery Into Primary Human Natural Killer Cells for Functional Gene AnalysesPouria Momayyezi, Karl-Johan Malmberg, Quirin Hammer
International Journal of Cancer|November 28, 2008
Natural killer cell-mediated lysis of freshly isolated human tumor cellsMattias Carlsten, Karl-Johan Malmberg, Hans-Gustaf Ljunggren
Experimental Cell Research|March 9, 2010
Tolerant and diverse natural killer cell repertoires in the absence of selectionSandra Andersson, Jenny-Ann Malmberg, Karl-Johan Malmberg
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Cancer Immunology, Immunotherapy : CII|September 1, 2004
Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape?Karl-Johan Malmberg
Cancer Cell|September 19, 2025
Rewiring natural killer cells for next-generation cancer therapiesAline Pfefferle, Karl-Johan Malmberg
Cell Calcium|October 7, 2020
Preventing a shock to the system. Two-pore channel 1 negatively regulates anaphylaxisSandip Patel, Karl-Johan Malmberg
Seminars in Cancer Biology|September 6, 2005
Escape from immune- and nonimmune-mediated tumor surveillanceKarl-Johan Malmberg, Hans-Gustaf Ljunggren
Nature Immunology|December 18, 2008
Spotlight on IL-22-producing NK cell receptor-expressing mucosal lymphocytesKarl-Johan Malmberg, Hans-Gustaf Ljunggren
Nature Reviews. Immunology|April 18, 2007
Prospects for the use of NK cells in immunotherapy of human cancerHans-Gustaf Ljunggren, Karl-Johan Malmberg
Blood Cancer Discovery|April 17, 2026
CAR-NK Cells in B-cell Lymphoma: A New Frontier toward Accessible and Scalable Cellular TherapyRémy Duléry, Karl-Johan Malmberg, Rizwan Romee
Current Protocols|November 28, 2022
Small Interfering RNA Delivery Into Primary Human Natural Killer Cells for Functional Gene AnalysesPouria Momayyezi, Karl-Johan Malmberg, Quirin Hammer
International Journal of Cancer|November 28, 2008
Natural killer cell-mediated lysis of freshly isolated human tumor cellsMattias Carlsten, Karl-Johan Malmberg, Hans-Gustaf Ljunggren
Experimental Cell Research|March 9, 2010
Tolerant and diverse natural killer cell repertoires in the absence of selectionSandra Andersson, Jenny-Ann Malmberg, Karl-Johan Malmberg
Pageof 13